Aug 14 (Reuters) - Suven Life Sciences Ltd SUVP.NS : * JUNE QUARTER NET PROFIT 388.4 MILLION RUPEES VERSUS PROFIT 295.7 MILLION RUPEES YEAR AGO * JUNE QUARTER TOTAL INCOME FROM...
Aug 7 (Reuters) - Suven Life Sciences Ltd SUVP.NS : * SAYS CO SECURES PRODUCT PATENTS IN MEXICO AND NEW ZEALAND * PATENT FROM MEXICO AND NEW ZEALAND CORRESPOND TO ENTITIES FOR...
July 16 (Reuters) - Suven Life Sciences Ltd SUVP.NS : * SAYS SECURES PRODUCT PATENTS IN EUROPE AND SOUTH KOREA * PRODUCT PATENTS RELATES TO NEW CHEMICAL ENTITIES FOR TREATMENT...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Buy||BUY||BUY||Strong Buy||Strong Buy|
|Summary||Strong Buy||Buy||Buy||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Engulfing Bearish||1W||3||Jul 29, 2018|
|Upside Gap Three Methods||1W||3||Jul 29, 2018|
|Engulfing Bearish||1D||3||Aug 16, 2018|
|Three Outside Down||1M||5||Mar 18|
|Engulfing Bearish||1M||6||Feb 18|
|L&T Finance Hld||185.50||188.80||185.05||-0.90||-0.48%||4.05M||14:01:28|
|Dr. Reddy's Labs||2,420.05||2,427.90||2,354.10||+39.30||+1.65%||444.44K||14:01:32|
Suven Life Sciences Limited is a bio-pharmaceutical company. The Company is engaged in the business of manufacture and sale of bulk drugs and intermediaries. The Company's segments include Manufacturing (CRAMS), which develops and produces bulk drugs and intermediates under contract manufacturing services; Services (DDDSS), which consists of collaborative research projects (CRP), clinical trials, and testing and analysis services, and Research and Development. Its products consist of active pharmaceutical ingredients (APIs), including Aripiprazole, Armodafinil, Calcium Acetate, Carprofen, Deferasirox, Doxofylline, Entacapone, Fenoprofen Calcium, Rosuvastatin Calcium, Sitagliptin Phosphate and Solifenacin succinate, and intermediates, including 2-nitro phenyl acetic acid and 3,4-dichlorobenzylamine. The Company is engaged in the drug discovery specializing in central nervous system (CNS)-based programs with over four of the molecules in pipeline under clinical phase of development.Read More
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.